Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
3,821.00
3,749.00
3,453.00
3,251.00
3,278.00
2,925.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
3,821.00
3,749.00
3,453.00
3,251.00
3,278.00
2,925.00
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
45.00
-63.00
68.00
15.00
-38.00
Raw Materials Consumed
1,346.00
1,345.00
1,398.00
1,215.00
1,340.00
1,294.00
Power & Fuel Cost
30.00
30.00
29.00
29.00
27.00
26.00
Employee Cost
607.00
579.00
624.00
594.00
610.00
616.00
Operating Expenses
101.00
114.00
113.00
99.00
120.00
110.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
178.00
167.00
163.00
161.00
178.00
104.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
55.00
72.00
68.00
68.00
58.00
75.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,512.00
2,571.00
2,545.00
2,447.00
2,516.00
2,327.00
Operating Profit (PBDIT) excl Other Income
1,309.00
1,177.00
908.00
804.00
761.00
598.00
Other Income
145.00
145.00
122.00
100.00
75.00
110.00
Operating Profit (PBDIT)
1,454.00
1,323.00
1,031.00
904.00
837.00
708.00
Interest
2.00
1.00
1.00
1.00
1.00
3.00
Profit before Depriciation and Tax
1,451.00
1,321.00
1,029.00
903.00
835.00
705.00
Depreciation
66.00
66.00
69.00
65.00
68.00
78.00
Profit Before Taxation & Exceptional Items
1,385.00
1,255.00
959.00
837.00
767.00
626.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
1,406.00
1,259.00
816.00
836.00
779.00
453.00
Provision for Tax
370.00
332.00
226.00
228.00
398.00
166.00
Profit After Tax
1,035.00
927.00
589.00
607.00
380.00
287.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,058.00
876.00
828.00
1,742.00
556.00
875.00
Profit Available for appropriations
2,094.00
1,804.00
1,418.00
2,350.00
936.00
1,162.00
Appropriations
2,094.00
1,804.00
1,418.00
2,350.00
936.00
1,162.00
Equity Dividend (%)
570.00%
540.00%
320.00%
320.00%
900.00%
300.00%
Earnings Per Share
61.15
54.76
34.83
36.05
100.04
21.14
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 1.93% vs 8.56% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 11.20% vs 29.57% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 107.99% vs -26.96% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 11.69% vs 57.23% in Mar 2025
Compare Profit and Loss Results of Glaxosmi. Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
3,821.00
4,208.00
-387.00
-9.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
3,821.00
4,208.00
-387.00
-9.20%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
-39.00
43.00
110.26%
Raw Materials Consumed
1,346.00
1,105.00
241.00
21.81%
Power & Fuel Cost
30.00
66.00
-36.00
-54.55%
Employee Cost
607.00
900.00
-293.00
-32.56%
Operating Expenses
101.00
168.00
-67.00
-39.88%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
178.00
417.00
-239.00
-57.31%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
55.00
85.00
-30.00
-35.29%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
2,512.00
3,036.00
-524.00
-17.26%
Operating Profit (PBDIT) excl Other Income
1,309.00
1,171.00
138.00
11.78%
Other Income
145.00
84.00
61.00
72.62%
Operating Profit (PBDIT)
1,454.00
1,256.00
198.00
15.76%
Interest
2.00
7.00
-5.00
-71.43%
Profit before Depriciation and Tax
1,451.00
1,249.00
202.00
16.17%
Depreciation
66.00
135.00
-69.00
-51.11%
Profit Before Taxation & Exceptional Items
1,385.00
1,113.00
272.00
24.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
1,406.00
1,113.00
293.00
26.33%
Provision for Tax
370.00
297.00
73.00
24.58%
Profit After Tax
1,035.00
816.00
219.00
26.84%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,058.00
3,141.00
-2,083.00
-66.32%
Profit Available for appropriations
2,094.00
3,957.00
-1,863.00
-47.08%
Appropriations
2,094.00
3,957.00
-1,863.00
-47.08%
Equity Dividend (%)
570%
2550%
-1,980.00
Earnings Per Share
61.15
64.82
-3.67
-5.66%
Profit And Loss - Net Sales
Net Sales 3,821.67 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.93% vs 8.56% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,309.20 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.20% vs 29.57% in Mar 2025
Profit And Loss - Interest
Interest 2.73 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 107.99% vs -26.96% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 1,035.98 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.69% vs 57.23% in Mar 2025